NEW YORK (GenomeWeb News) – Celera reported after the close of the market on Tuesday that its revenues for the third quarter of calendar 2008 rose 284 percent while it swung from a profit to a loss due to higher SG&A spending and some charges to earnings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.